Micro Medical Solutions Appoints Board of Directors

WOBURN, Mass., March 20, 2025 /PRNewswire/ -- Micro Medical Solutions (MMS), a pioneering medical device startup focused on revolutionizing the treatment of Critical Limb Ischemia (CLI), is proud to announce the appointment of a distinguished Board of Directors. This distinguished leadership will provide strategic guidance as MMS advances its groundbreaking medical technologies to improve patient outcomes worldwide.

Along with MMS CEO & Chairman of the Board, Greg Sullivan, the newly appointed Board of Directors includes:

• John Fletcher, Managing Partner Emeritus, Fletcher Spaght, Inc. John currently serves as Chairman of the Board of Directors for ClearPoint Neuro, Koru Medical, Metabolon and Optinose. He served as Chairman of Spectranetics during its turnaround and subsequent sale to Philips N.V. For this work as well as his work on the board of Axcelis Corporation, he was selected as Director of the Year by the National Association of Corporate Directors. He is Chairman Emeritus of the Corporate Collaboration Council at the Thayer School of Engineering/Tuck School of Business at Dartmouth College and serves on the Board of Advisors of Beth Israel Deaconess Medical Center and the Whitehead Institute at MIT.
• George Quinoy is a seasoned C-suite executive with a proven track record of building and scaling commercial enterprises in the vascular space. He has led high-growth strategies that resulted in successful acquisitions by key industry leaders. Throughout his career, George has played a pivotal role in driving rapid and sustained expansion for renowned companies, including AVE, Medtronic, ACS/Guidant, Volcano Corp, and most recently, Provisio Medical. His leadership continues to shape the vascular innovation and commercialization.
• Joseph Ruggio, MD,a renowned cardiologist and founder, and president of Pacific Cardiovascular Associates Medical Group, Inc. (PCA). Dr. Ruggio serves as President and Chief Medical Officer of Via Vitae MSO, LLC, a partnership with Optum Specialty Practices. Board-certified in internal medicine, cardiovascular diseases, and interventional cardiology, he brings extensive clinical and leadership expertise.
• Ronald Solar, PhD, Dr. Ronald Solar received his Ph.D. in Biomaterials and Materials Science from the University of Pennsylvania and has been designing and developing medical devices for over 45 years. He co-founded several successful medical device companies, including Y Med (sold to CR Bard), X Technologies (sold to Guidant), Pameda/Occam (sold to Cordis) and Versaflex (sold to Medtronic). Dr. Solar also played key leadership and development roles for Edwards Life Sciences, Advanced Cardiovascular Systems, SciMed and Medtronic.  He currently holds over 68 US patents.

"We are honored to welcome such an eminent group of experts to our Board," said CEO, Greg Sullivan. "Their collective experience in medical device innovation, regulatory strategy, and market expansion will be instrumental as we scale our transformative solutions, like the MicroStent™, to meet the evolving critical vascular challenges of interventionalists and their patients"

About MMS
For more information about Micro Medical Solutions and its mission to transform healthcare, visit www.micromedicalsolutions.net .

Media Contact:
Peg Thornton
VP, Strategic Initiatives
[email protected]
732-616-9123

SOURCE Micro Medical Solutions